The foundation supports scientists and researchers in their efforts to determine the definitive causes of triple negative breast cancer so that effective detection, diagnosis, prevention, and treatment can be pursued and achieved.

In response to her diagnosis, her close friends launched the TNBC Foundation to raise awareness and support research for this particular type of breast cancer.

Worth $7.5 million over five years, Promise Grants are designed to bring clinical researchers and basic scientists together to deliver new treatments for patients as quickly as possible.

These free online forums allow members of the TNBC community to connect, share information, exchange treatment tips, and support each other during a participant-led discussion.

[10] On December 11, 2007, the TNBC Foundation and Susan G. Komen for the Cure convened one of the first "think tanks" dedicated specifically to triple negative breast cancer.

[11] The goal of the meeting was to create the first comprehensive publication and white-paper summarizing the "state of the science" with input and authorship from leading researchers from around the world who have been dedicated specifically to this subtype of the disease.

The publication will also include a roadmap and recommendations for planning, funding and designing the next level of research with the goal of identifying effective, tailored therapies for these women, thereby further reducing the rates of breast cancer mortality around the world.

The program was planned by TNBC's medical advisory board, which includes Dr. Winer as well as Lisa A. Carey, medical director of the University of North Carolina Lineberger Comprehensive Cancer Center, and George W. Sledge, Jr., professor of Medicine and Pathology and co-chair of the Breast Cancer Program at the Indiana University School of Medicine.